Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Artificial Intelligence Among US Hematology Oncology Fellows: A Multicenter Survey of Education, Attitudes, and Clinical Use.
Journal: JCO oncology practice
Published: May 31, 2026
Corrigendum to Comprehensive clinical characteristics and outcomes of stage IV EGFR-mutant NSCLC based on PD-L1 expression, Cancer Treatment and Research Communications 46 (2026) 101109.
Journal: Cancer treatment and research communications
Published: May 03, 2026
Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison.
Journal: Journal of comparative effectiveness research
Published: December 15, 2025
Comprehensive clinical characteristics and outcomes of stage IV EGFR-mutant NSCLC based on PD-L1 expression.
Journal: Cancer treatment and research communications
Published: December 15, 2025
Second-line therapy following osimertinib in metastatic EGFR-mutated non-small cell lung cancer at an academic medical center.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
The impact of preoperative imaging strategies in EGFR-mutant non-small cell lung cancer: a multicenter retrospective review.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Design and Creation of a Racially Diverse Lung Cancer Registry with Detailed Genomic and Environmental Annotation.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: June 24, 2025
The impact of eligibility criteria on Kirsten rat sarcoma G12C inhibitor trials in patients with non-small cell lung cancer.
Journal: Journal of the National Cancer Institute
Published: April 24, 2025
Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non-small cell lung cancer.
Journal: The Journal of thoracic and cardiovascular surgery
Published: April 01, 2025
Sleep disruption in patients with active and treated endogenous Cushing's syndrome.
Journal: Pituitary
Published: August 22, 2024
Comparative Efficacy and Safety of Lorlatinib Versus Alectinib and Lorlatinib Versus Brigatinib for ALK-Positive Advanced/Metastatic NSCLC: Matching-Adjusted Indirect Comparisons.
Journal: Clinical lung cancer
Published: February 29, 2024
Last Updated: 09/26/2026